Successful use of rituximab, an anti‐CD20 monoclonal antibody, to treat IgA nephropathy in a patient with recessive dystrophic epidermolysis bullosa
Sign Up to like & getrecommendations! Published in 2022 at "Clinical and Experimental Dermatology"
DOI: 10.1111/ced.15228
Abstract: lesions are caused by alterations of the immune system caused by the systemic diseases with which the disorder is associated. These alterations trigger an excessive inflammatory reaction in response to bacterial infections or other external… read more here.
Keywords: pemphigus vegetans; psv pdv; patient; use rituximab ... See more keywords